For those new, the following is extremely heavy on the

New Post Public Reply Private Reply Replies (1) Message Board
petemantx
1,106
For those new, the following is extremely heavy on the sarcasm.

The last few weeks seems to have proven what so many on this board keep trying to tell us, there is absolutely no nefarious doings being played by outsiders (whether MMs, hedge funds, cabals, major trading groups, whomever)against IPIX. There are very few shorts and for certain no naked shorts (of course, if there were wouldn't the "naked" mean they couldn't be traced?). What we have is a perfectly trading market adhering to all the rules put in place by the SEC. If any of the named bodies above were fiddling with the trading, we certainly would be protected by FINRA who would throw the top management of firms doing such brazen thievery in jail (or more likely give them a a token slap on the wrist, tell them not to do it again, and let them keep about 95% or more of the money they filched from honest investors with their illegal dealings.

Now how can I support such belief in the system such that it must have been bad company news that sent the stock price dropping? See the following:

1- B found to be one of only a handful of drugs found to be lethal to CV19 via computerized model of over 11K drugs.
2- Further testing by a govt lab showed B exceptionally effective in killing CV in a petri dish.
3- Further testing showed B killed 85% of CV19 within an hour against an extremely tough strain of CV19 in human kidney tissue
4- Further testing showed B killed 97% of CV19 in human lung tissue.
5- RBL that did the lab work on the human lung tissue (and had worked with B since 2018 against antifungals was so impressed with the results that they co-authored a grant request to do a PAN-CORONA investigation of B.
6- Both RBLs plan on publishing peer review articles of the work and findings they did on B because the results were so stellar.
7- Further testing at RBL showed at the lowest dose given to date B still showed a 90% effective kill rate of CV19 whereas Remsdesivir only showed a 50% kill rate. Thus, the SI (selectivity index), which is a great aid in determining those drugs with the highest expected success rate against CV19 and the safest, should be MUCH higher for B compared to Rems....
8- Testing results listed above shows that Brilacidin should kick Rems.... ass in a head to head trial.
9- Govt has already committed to a $2B order for Rems.... product. What would they commit to a product that wipes out Rems...?
10- Grant request was submitted in early July and keeps getting closer and closer to being announced.
11- B's 3 MOAs against CV19 gives it a Billion X Billion greater chance of viruses not being able to develop a resistance to it compared to all other drugs that have only a single MOA to kill CV19.
12- B's 3-in-1 properties of being antibacterial, anti-inflammatory, antiviral, and having strong immunotherapeutic properties makes it able to attack the results of the CV19 such as lung cell death, brain swelling, kidney disruption, bowel disruption, cytokine storm, etc while most every other drug just is able to try and kill the virus to a far, far less greater effect than B.
13- B does not alter the DNA of the human genome. Most other major drugs being discussed, especially for developing a virus, affect the DNA in a recombinant or like manner and to date NO DRUG HAS EVER BEEN tested to see what the long term effects on humans is of these drugs. But then, who doesn't mind for-profit companies playing with the human genome?

I think the above has pretty much made my point. Why wouldn't all stock holders have realized the price would plummet of our shares when we have been faced with the above body of news? Who would ever have thought such mind boggling success after success for B against CV wouldn't have set BIG MEDICINE on its ear (or maybe that is one of the problems, BIG MEDICINE realizes what a threat Brilacidin brings to SO MANY of their drugs which don't cure anything, just treats conditions for life long needed therapies off of which they happen to make a fortune? Who wouldn't have expected a major drop almost daily at the last second and a major drop right out of the gate in the first 15 minutes of trading by the MMs?

Yes, I now realize I should pity all us dumb long stock holders for the rose-colored glasses we have been wearing. Even a fool could look at the data above and see we were headed in an ever increasing spiral down in share price.

And if you believe that, you are most likely profiting from this unconscionable attack on IPIX. Not blaming the traders that buy and sell daily, that is all part of the game. But the larger game is being allowed by the regulatory bodies IMO and though they know how to fix the system the big money says to keep their hands off - and so they do.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 4

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 4

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 4

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
B2B Growth Hinges on Narrative Coherence, Study Shows

Updated Category News Views 5

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....

Continue Reading
ScholarShare 529 Launches $50 Back-to-School Promo

Updated Category News Views 5

California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 4

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
Jacob Walthour to Be Honored for Economic Leadership

Updated Category News Views 5

The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...

Continue Reading
2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 6

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 5

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading
American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 6

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading

Top 5 Most Recently Viewed Articles

Houlihan Lokey Reaches New Peak with $162.91 Stock Value

Updated Category News Views 145

Houlihan Lokey Achieves All-Time High Recently, shares of Houlihan Lokey (NYSE:HLI) Inc reached an impressive all-time high of $162.91. This milestone is indicative of the strong market confidence and positive investor sentiment surrounding the global investment bank. The stock has experienced remarkable growth, rising by 50.22% within the last year, largely driven by the...

Continue Reading
Mister Car Wash Transitioning Stock Listing to Nasdaq Markets

Updated Category News Views 113

Mister Car Wash Transitioning to Nasdaq Mister Car Wash, Inc. (NYSE: MCW), recognized as the largest car wash brand in the nation, is making a significant move in the financial market. The company has announced its intention to voluntarily transfer its common stock listing from the New York Stock Exchange to the Nasdaq Global Select Market. This transition is set to occur...

Continue Reading
Polaris Inc. Announces Upcoming Earnings Call for 2024

Updated Category News Views 201

Polaris Inc. Earnings Conference Call Announcement Polaris Inc. (NYSE: PII) has exciting news to share regarding their financial reporting schedule. The company is set to release its fourth quarter and full year 2024 financial results soon. This report will be made available on the company’s official website, providing insights into their performance over the past year....

Continue Reading
Charmaine Carmichael Joins Trifork as COO and UK Director

Updated Category News Views 426

Trifork Welcomes Charmaine Carmichael Trifork, a leading technology innovation partner, has recently made an exciting announcement regarding its leadership structure. The company has appointed Charmaine Carmichael to the newly created position of Group Chief Operating Officer (COO) and Director of Trifork UK. This strategic move aims to reinforce their commitment to...

Continue Reading
Duchesnay Pharmaceutical Group Achieves 2025 Healthiest Workplace

Updated Category News Views 209

Duchesnay Pharmaceutical Group Achieves Prestigious Recognition Duchesnay Pharmaceutical Group (DPG) has recently been awarded the 2025 Healthiest Workplace Award by Dialogue Health Technologies Inc. This accolade marks a significant achievement for DPG, showcasing the company's unwavering commitment to the well-being of its employees. Known for its innovative approaches...

Continue Reading